Direct binding and repression of KRAS by miR-1 have been demonstrated in several tumor types, suggesting that KRAS may also contribute to miR-1-mediated tumor suppression in CCA [41,42]. The gene discussed is KRAS; the disease is cholangiocarcinoma.